Prostate cancer drug that can halve death risk to be offered to thousands in England
At least 6,000 men a year with hormone-sensitive cancer to get access to darolutamide, which blocks growth with fewer side-effects Thousands of men with advanced prostate cancer in England are to be offered a drug that can halve the risk of death. In guidance published on Friday, the National (…)
Site référencé:
The Guardian (Asia Pacific)
3333.jpg?width=140&quality=85&auto=format&fit=max&s=4ef98f38f4c778416f19eff8a360aecc, 3333.jpg?width=460&quality=85&auto=format&fit=max&s=1150db78d91fedf560db661d7de6d353, 3333.jpg?width=700&quality=85&auto=format&fit=max&s=b88b50e1202d2797417341d7e43a97ab
The Guardian (Asia Pacific)
Caerphilly byelection result live : Plaid Cyrmu beats challenge from Reform UK to win pivotal Welsh parliament vote
24/10/2025
In the depths of the ocean, a new contest between the US and China emerges
24/10/2025
Trump in Asia : five key questions as US president prepares for diplomatic tour
24/10/2025
Trump news at a glance : Trump scraps plan to send federal troops to San Francisco Bay Area
24/10/2025
Booker prize launches £50,000 children’s award
24/10/2025
Surge in UK savings lost to investment scams, with fake crypto thought to top the list
24/10/2025